Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Extem Pharma AB
AB
Active
Org 5594742198
Vallongatan 1, 752 16
Uppsala
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2024 · 2 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Extem Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
-1M
-100%
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
−0
0
Staff expenses
−66
−415
EBITDA
−90
−691
Depreciation & amort.
—
−9
EBIT
−90
−700
Net financials
1
1
Profit before tax
−89
−698
Tax
—
—
Net profit
−89
−698
Balance sheet
SEK thousands
Item
2024
2025
Total assets
410
4 284
Equity
186
4 022
Long-term debt
—
—
Short-term debt
224
262
Total debt
224
262
Financial ratios
5-year trend
EBITDA margin
-34539100.0%
This company
15.8%
Market median
-218601999% vs market
2024
2025
Equity ratio
93.9%
This company
38.2%
Market median
+146% vs market
2024
2025
Return on equity
-17.4%
This company
18.4%
Market median
-195% vs market
2024
2025
Net profit margin
-34912550.0%
This company
8.1%
Market median
-431019236% vs market
2024
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-03-01 – 2024-12-31
View
PDF
More on Extem Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
